IRCT2012072210363N1
Completed
未知
An open trial of Duloxetine in the treatment of children with attention-deficit/hyperactivity disorder
niversity of Social Welfare and Rehabilitation Sciences0 sites10 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Attention Deficit Hyperactivity Disorder(ADHD).
- Sponsor
- niversity of Social Welfare and Rehabilitation Sciences
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria : ADHD diagnosis according to DSM\-IV\-TR that is applied by two psychiatrists; age between 6\-12 years old
- •Exclusion criteria : mental retardation; history of heart disease; drug sensitivity; comorbidity of severe mental illnesses such as bipolar disorder, major depressive disorder, conduct disorder, psychosis ; history of seizure.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 3
A Phase III Clinical Trial of Duloxetine in Participants With FibromyalgiaFibromyalgiaJPRN-jRCT2080221737SHIONOGI & CO., LTD.
Unknown
Phase 3
A phase 3 clinical trial of duloxetine in patients with osteoarthritisJPRN-jRCT2080222625Shionogi & Co., Ltd.
Unknown
Phase 3
A phase 3 clinical trial of duloxetine in patients with chronic low back paiChronic low back painJPRN-jRCT2080222083SHIONOGI & CO., LTD.
Recruiting
Phase 2
The use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathyChemotherapy-induced peripheral neuropathyNeurological - Other neurological disordersCancer - Any cancerACTRN12617000139370Prince of Wales Hospital48
Completed
Phase 4
An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety DisorderIrritable Bowel SyndromeGeneralized Anxiety DisorderNCT00961298West Penn Allegheny Health System17